B. Riley Financial, Inc. Enanta Pharmaceuticals Inc Put Options Transaction History

B. Riley Financial, Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$65.41 - $84.65 $654,100 - $846,500	-10,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $854,599 - $1.26 Million	10,000 New	10,000 $855,000

109

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $107M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.